Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

New circular external fixator device for diabetic Charcot foot treatment

The alarming increase of morbidly obese diabetics is causing more new cases of a debilitating foot deformity called Charcot foot.Charcot foot can make walking difficult or impossible, and in severe cases can require amputation.But a surgical technique that secures foot bones with an external frame has enabled more than 90 percent of patients to walk normally again.

15 Jul 2010

American Heart Association comments on FDA advisory committee's rosiglitazone recommendations

After two days of hearings, an advisory committee to the U.S. Food and Drug Administration (FDA) recommended that the FDA allow the type 2 diabetes drug rosiglitazone (brand name, Avandia), to stay on the market, but with most committee members suggesting that the label be revised to include increased warnings. Rosiglitazone is one in a class of drugs called thiazolidinediones (TZDs), used to treat type 2 diabetes.

15 Jul 2010

Children's National and George Washington University receive NIH Clinical and Translational Science Award

Children's National Medical Center, in partnership with The George Washington University Medical Center, has received a prestigious Clinical and Translational Science Award (CTSA) from the National Center for Research Resources of the National Institutes of Health.

15 Jul 2010

GSK confirms FDA advisory committees' vote to allow Avandia to remain on the market

GlaxoSmithKline confirmed today that a joint advisory committee to the U.S. Food and Drug Administration (FDA) voted to allow Avandia to remain on the market. Committee members voted for recommendations ranging from making no changes to the current label, to revising the label with additional warnings and restrictions to withdrawal from the U.S. market.

15 Jul 2010

Evotec to acquire DeveloGen

Evotec AG today announced the signing of a definitive agreement to acquire DeveloGen, a biopharmaceutical company engaged in the discovery of novel therapeutic approaches for the treatment of metabolic and endocrine disorders, for up to €14m in shares plus performance-related deferred payments (earn-out).

15 Jul 2010

BioInvent reports net revenues of SEK 63.1M for January - June 2010 period

BioInvent reached an important milestone when the results of a phase II trial of TB-402 following orthopaedic surgery, were reported in May. The data showed that TB-402 is statistically better at preventing thrombosis than enoxaparin, the current standard treatment. Supported by these good results, BioInvent and the company's partner, ThromboGenics, will now prioritise securing a development partner for the programme to ensure that the necessary resources is in place to take the product candidate to the market.

14 Jul 2010

Circular external fixator enables over 90% of Charcot foot patients to walk normally again

The alarming increase of morbidly obese diabetics is causing more new cases of a debilitating foot deformity called Charcot foot.

14 Jul 2010

AD may lead to increased risk of comorbid conditions, research shows

Pfizer Inc., together with its collaborator on the Alzheimer's Immunotherapy Program, Janssen Alzheimer Immunotherapy, presented new research this week at the Alzheimer's Association International Conference on Alzheimer's Disease 2010 from two podium and four poster presentations.

14 Jul 2010

Susceptibility to Behcet's disease associated with genes involved in body's immune response

Researchers with the National Institutes of Health have found susceptibility to Behcet's disease, a painful, inflammatory condition, to be associated with genes involved in the body's immune response.

14 Jul 2010

Predictors of an Asian diabetes epidemic: A study

Experts believe diabetes will be the leading disease in Asia mainly because of the rise in consumption of junk and high calorie foods in this region of the world.

13 Jul 2010

FDA to decide on Avandia’s fate Wednesday

Avandia, a drug used as a treatment for type 2 diabetes was approved for use in 1999. However controversies have surrounded it since 2007 when a Cleveland Clinic cardiologist Steven E. Nissen published a study in the acclaimed New England Journal of Medicine that concluded that the drug significantly increased the risk for heart problems like heart attacks, heart failure and deaths.

13 Jul 2010

Women with gestational diabetes during first, second pregnancies at increased risk of recurrence

There is an increased risk of recurring gestational diabetes in pregnant women who developed gestational diabetes during their first and second pregnancies, according to a Kaiser Permanente study appearing online in The American Journal of Obstetrics and Gynecology.

13 Jul 2010

Finalists for Best Practices in Health Care Consumer Empowerment and Protection Awards announced

URAC announced today that a distinguished panel of judges has selected 30 finalists for its Best Practices in Health Care Consumer Empowerment and Protection Awards. The competition drew entries from across the nation. The finalists will be honored during URAC's 11th Annual Quality Summit, October 5-7, 2010 in Chicago, IL. The awards honor programs in two areas: Consumer Decision-Making and Consumer Health Improvement.

13 Jul 2010

Researchers identify genetic variant associated with increased risk of AAA

Geisinger researchers are part of an international team that has identified a genetic variant more common in individuals with abdominal aortic aneurysms. This is one of the largest studies ever into the genetics of AAA. The results of the work will appear in this week's online edition of Nature Genetics.

13 Jul 2010

Kid cholesterol

According to a new study published in the 12th July issue of the journal Pediatrics, one third of kids have blood cholesterol on the higher side and these levels might be overlooked with the current screening recommendations.

13 Jul 2010

Older adults with low levels of vitamin D more likely to experience cognitive decline: Report

Older adults with low levels of vitamin D appear more likely to experience declines in thinking, learning and memory over a six-year period, according to a report in the July 12 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

13 Jul 2010

Stanford University, OHSU receive grants to study VIAject for treating patients with diabetes

Biodel Inc. announced today the award of two research grants by the Juvenile Diabetes Research Foundation to Stanford University and Oregon Health & Science University to evaluate the use of VIAject (ultra-rapid-acting injectable human insulin) in the treatment of diabetes.

12 Jul 2010

Reata funds second pivotal trial of bardoxolone with $78 million equity financing

Reata Pharmaceuticals, Inc. has completed a $78 million equity financing led by existing investors CPMG, Inc. and Novo A/S. This financing brings the total raised by the Company to $180 million since inception.

12 Jul 2010

Common SNP in sequence of human genome conferring risk of vascular diseases discovered

Scientists at deCODE genetics and academic colleagues from the Netherlands and twelve other countries across Europe and North America today report the discovery of a common single-letter variation (SNP) in the sequence of the human genome conferring risk of a range of vascular diseases. The SNP confers risk of abdominal aortic aneurysm (AAA), early-onset heart attack, peripheral artery disease (PAD), and pulmonary embolism, independent of other known risk factors.

12 Jul 2010

Addition of fat to mouse stem cells push them to develop into subcutaneous or visceral fat storage cells

New research being presented today (12 July) at the UK National Stem Cell Network Annual Science Meeting in Nottingham shows that adding fat to mouse stem cells grown in the lab affects their response to the signals that push them to develop into one or other of the main types of fat storage cells - subcutaneous (under the skin) or visceral (around the organs).

12 Jul 2010

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

New circular external fixator device for diabetic Charcot foot treatment

American Heart Association comments on FDA advisory committee's rosiglitazone recommendations

Children's National and George Washington University receive NIH Clinical and Translational Science Award

GSK confirms FDA advisory committees' vote to allow Avandia to remain on the market

Evotec to acquire DeveloGen

BioInvent reports net revenues of SEK 63.1M for January - June 2010 period

Circular external fixator enables over 90% of Charcot foot patients to walk normally again

AD may lead to increased risk of comorbid conditions, research shows

Susceptibility to Behcet's disease associated with genes involved in body's immune response

Predictors of an Asian diabetes epidemic: A study

FDA to decide on Avandia’s fate Wednesday

Women with gestational diabetes during first, second pregnancies at increased risk of recurrence

Finalists for Best Practices in Health Care Consumer Empowerment and Protection Awards announced

Researchers identify genetic variant associated with increased risk of AAA

Kid cholesterol

Older adults with low levels of vitamin D more likely to experience cognitive decline: Report

Stanford University, OHSU receive grants to study VIAject for treating patients with diabetes

Reata funds second pivotal trial of bardoxolone with $78 million equity financing

Common SNP in sequence of human genome conferring risk of vascular diseases discovered

Addition of fat to mouse stem cells push them to develop into subcutaneous or visceral fat storage cells

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in